Arvinas, Inc. vs Pfizer, Inc. — Stock Comparison

ARVN
Arvinas, Inc.
$10.51
▲ 6.16%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5/10

Q·Score Breakdown

5
Bearish
Overall
6.5
Neutral
0.8
Quality
7.4
9.2
Health
7
4.3
Growth
5.6
6.3
Valuation
6.7
5.9
Sentiment
5.2
ARVN

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-31% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $14.88 (+41.5%)
16 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

ARVN
PFE
Trailing P/E
19.4×
-3.0×
Forward P/E
9.4×
-30.8%
Profit Margin
12.4%
100.0%
Gross Margin
75.8%
-16.2%
ROE
8.9%
-84.0%
Revenue Growth
-1.2%
Earnings Growth
1.98
Beta
0.39
Price / Book
$672M
Market Cap
$149.8B
$6 – $15
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →